| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO | Director, Senior Advisor +1 more
1 company
Posner Christopher is a President And CEO at Tvardi Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $55K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2023 | TVRD Tvardi Therapeutics, Inc. | President And CEO | Sell | 3,869 | $4.40 | $17,023.60 | -2.2% | -27.3% | -82.3% | |
| Mar 3, 2023 | TVRD Tvardi Therapeutics, Inc. | President And CEO | Sell | 5,987 | $9.71 | $58,133.77 | -3.3% | -69.9% | -90.8% | |
| Feb 2, 2023 | TVRD Tvardi Therapeutics, Inc. | President And CEO | Sell | 4,191 | $11.80 | $49,453.80 | -2.2% | -64.8% | -95.2% | |
| Nov 16, 2022 | TVRD Tvardi Therapeutics, Inc. | President And CEO | Sell | 14,470 | $11.13 | $161,051.10 | -7.2% | -4.2% | -90.2% | |
| Apr 4, 2022 | TVRD Tvardi Therapeutics, Inc. | President And CEO | Sell | 2,006 | $12.67 | $25,416.02 | -1.0% | -26.6% | -62.3% | |
| Jun 7, 2021 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 2,304 | $13.04 | $30,044.16 | -12.5% | +16.0% | -34.1% | |
| Nov 19, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 2,000 | $15.82 | $31,638.00 | -15.2% | - | - |